Medicines Formulary

Medicines A–Z

A

Drug name	NICE TAs	Comments
Aclidinium inhaler (Eklira Genuair)		For COPD only
Actikerall
Adalimumab	TA187 - Infliximab and adalimumab for the treatment of Crohn's disease TA329 - Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262)
Adalimumab syringe	TA199 - Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis TA195 - Drugs for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor TA143 - Adalimumab , etanercept and infliximab for ankylosing spondylitis TA130 - Adalimumab , etanercept and infliximab for the treatment of rheumatoid arthritis TA373 - Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA715 - Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed
Adalimumab	TA146 - Adalimumab for the treatment of adults with psoriasis TA392 - Adalimumab for treating moderate to severe hidradenitis suppurativa
Adapalene		Avoid in pregnancy
Adapalene with benzoyl peroxide (Epiduo®)		First choice
Adcal-D3 tablets
Adenosine injection		Hospital only
Adrenaline / Epinephrine (Epipen)		Jext® and Epipen®

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.